logo-brainhq-hi-res-hori.png
Study: New Intervention Helps with Alcohol-related Cognitive Impairment
December 14, 2020 08:00 ET | Posit Science
SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Researchers at Yale published positive results from a pilot study of a novel combination therapy in patients with Mild Cognitive Impairment related...
Logo_final_color.png
Cybrexa Therapeutics Expands Scientific Advisory Board With Appointment of Leader in Lung Cancer Research Roy Herbst, M.D., Ph.D.
August 03, 2020 07:00 ET | Cybrexa Therapeutics
NEW HAVEN, Conn., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ tumor targeting...
Logo_final_color.png
Cybrexa Therapeutics to Present First Efficacy and Safety Data From Its Lead Program CBX-12 and Initial Data From CBX-13 at the American Association for Cancer Research (AACR) Virtual Annual Meeting II
May 15, 2020 04:00 ET | Cybrexa Therapeutics
NEW HAVEN, Conn., May 15, 2020 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, an oncology-focused biotechnology company developing a new class of therapeutics through its alphalex™ tumor targeting...
Logo_final_color.png
Cybrexa Therapeutics Announces Expansion of Its Anticancer Pipeline
December 09, 2019 08:30 ET | Cybrexa Therapeutics
NEW HAVEN, Conn., Dec. 09, 2019 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a biotechnology company developing a new class of cancer therapeutics through its alphalex™ tumor targeting platform, today...
ReNetX_logo1.png
ReNetX Bio Announces Initiation of Patient Dosing in the First Phase 1 Clinical Trial of Fusion Protein AXER-204
August 14, 2019 09:02 ET | ReNetx Bio
NEW HAVEN, Conn., Aug. 14, 2019 (GLOBE NEWSWIRE) -- ReNetX Bio, Inc., a leading biotechnology company committed to reversing disease and damage for patients suffering from central nervous system...
Gofire-Logo-1080.png
Rise in Medical Cannabis Research Spurs Demand For Precise Measurement Tools
June 05, 2019 09:00 ET | Gofire, Inc.
DENVER, June 05, 2019 (GLOBE NEWSWIRE) -- Healthcare technology firm Gofire™, an innovator of hardware and software solutions that aid in dose delivery, health tracking, and medication management,...
Ossa Fisher Named Istation’s President
January 08, 2019 10:28 ET | Istation Inc.
Dallas, TX, Jan. 08, 2019 (GLOBE NEWSWIRE) -- Ossa Fisher is the new president of Istation, a Dallas-based education technology company providing computer-adaptive assessments and instruction in...
Farooq Kathwari Honored With Yale Chief Executive Leadership Institute's Lifetime of Leadership Award
June 21, 2018 14:01 ET | Ethan Allen
DANBURY, Conn., June 21, 2018 (GLOBE NEWSWIRE) -- Ethan Allen chairman, president and CEO Farooq Kathwari accepted the Yale Chief Executive Leadership Institute's (CELI) Lifetime of Leadership Award...
ReNetX_logo1.png
Remedy Pharmaceuticals Co-founder and CEO Brings Clinical Trial and Company-Building Experience to ReNetX Bio Advisory Board
February 12, 2018 10:00 ET | ReNetX Bio
NEW HAVEN, Conn., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Sven Jacobson will be the first to admit that developing a new therapeutic for spinal cord injury is a challenging road. But the latest member of...
Predictive Technology Group Appoints Dr. Hugh S. Taylor, M.D. to the Predictive Technology Group's Scientific Advisory Board
January 04, 2018 09:00 ET | PREDICTIVE TECHNOLOGY GROUP, INC.
SALT LAKE CITY, Utah, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK:PRED) announces that Dr. Hugh S. Taylor, M.D., joined the Predictive Technology Group’s Scientific...